Effectiveness and Safety of Early Short-Course, Moderate- to High-Dose Glucocorticoids for the Treatment of Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis: A Retrospective Study-Reference-Cited by-同舟云学术

Effectiveness and Safety of Early Short-Course, Moderate- to High-Dose Glucocorticoids for the Treatment of Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis: A Retrospective Study

Published:2022-09 Issue: Volume:Volume 15 Page:1979-1990
ISSN:1178-7015
Container-title:Clinical, Cosmetic and Investigational Dermatology
language:en
Short-container-title:CCID

Author:

Ye Zhenzhen,Li Chunting,Zhang Hua,Zhang Chunlei,Lu Xueyan

Publisher

Informa UK Limited

Subject

Dermatology

Reference26 articles.

1. Toxic epidermal necrolysis: a paradigm of critical illness

2. SJS/TEN 2017: Building Multidisciplinary Networks to Drive Science and Translation

3. Incidence of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Nationwide Population-Based Study Using National Health Insurance Database in Korea

4. U.K. guidelines for the management of Stevens–Johnson syndrome/toxic epidermal necrolysis in adults 2016

5. Research Center for Adverse Drug Reactions, Dermatology and Venereology Branch of Chinese Medical Association. Expert consensus on diagnosis and treatment of Stevens-Johnson syndrome/toxic epidermal necrolysis. Chin J Dermatol. 2021;54(05):376–381.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A case of Stevens-Johnson syndrome treated with oral cyclosporine;Journal of Family Medicine and Primary Care;2023-12

2. Stevens-johnson Syndrome and Toxic Epidermal Necrolysis: An Overview of Diagnosis, Therapy Options and Prognosis of Patients;Recent Advances in Inflammation & Allergy Drug Discovery;2023-09

3. RDW-SD and PCT Are Potential Prognostic Factors for In-hospital Death in Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis;Allergy, Asthma & Immunology Research;2023